Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterization of dysfunctional factor VIII molecules

L W Hoyer1

  • 1Holland Laboratory, American Red Cross, Rockville, Maryland 20855.

Methods in Enzymology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.

Thrombosis research·2001
Same author

Characterization of the immune response to factor VIII using hemophilia A* mice.

Haematologica·2001
Same author

Mechanism of the immune response to human factor VIII in murine hemophilia A.

Thrombosis and haemostasis·2001
Same author

Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.

European journal of immunology·2000
Same author

Prevention and treatment of factor VIII inhibitors in murine hemophilia A.

Blood·2000
Same author

Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.

Thrombosis and haemostasis·1999

Researchers identified specific molecular defects in hemophilia A patients by analyzing dysfunctional factor VIII molecules. This helps understand how structural changes impact factor VIII function and blood clotting.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Hemophilia A is a bleeding disorder caused by factor VIII deficiency or dysfunction.
  • CRM-positive and CRM-reduced hemophilia A involve dysfunctional factor VIII molecules.
  • Understanding structural defects is crucial for correlating them with molecular causes.

Purpose of the Study:

  • To immunopurify and characterize dysfunctional factor VIII-like molecules in hemophilia A.
  • To correlate structural changes in factor VIII with specific molecular defects.
  • To investigate the molecular basis of factor VIII dysfunction.

Main Methods:

  • Immunopurification of factor VIII-like molecules.
  • Characterization of molecular mass and enzymatic fragments of factor VIII chains.

Related Experiment Videos

  • Gene sequencing to identify mutations responsible for factor VIII dysfunction.

    • Main Results:

    • Developed a sensitive technique to characterize factor VIII in patients with low factor VIII antigen levels (as low as 0.05 U/ml).
    • Identified specific abnormalities in 5 out of 24 tested samples.
    • Discovered mutations affecting thrombin cleavage sites and creating new N-glycosylation sites.

    Conclusions:

    • The described technique is effective for studying factor VIII structure-function relationships.
    • Identified mutations provide insights into the molecular basis of factor VIII dysfunction in hemophilia A.
    • This approach can further clarify the molecular basis of factor VIII procoagulant activity.